Method in eye surgery

1. Method for forming an intraocular lens in situ in an eye of a mammal, comprising: removing the natural lens of the eye from the capsular bag; introducing an object comprising a capsular equatorial ring provided with at least one sharp edge into the capsular bag, with the sharp edge contacting an inside wall of the capsular bag to form a barrier preventing migration of epithelial cells across the barrier; injecting a lens-forming composition into the capsular bag; and allowing the lens-forming composition to cure to form an intraocular lens in the capsular bag, wherein the sharp edge remains in contact with an inside wall of the capsular bag after lens formation to prevent migration of epithelial cells across the barrier in the capsular bag.

2. Method according to claim 1 , in which the object with at least one sharp edge contacts the inside of the capsular bag along an equator of the capsular bag.

3. Method according to claim 2 , in which the object with at least one sharp edge contacts the inside wall of the capsular bag along at least 50% of the equator of the capsular bag.

4. Method according to claim 3 , in which the object with at least one sharp edge contacts the inside wall of the capsular bag along at least 75% of the equator of the capsular bag.

5. Method according to claim 4 , in which the object with at least one sharp edge contacts the inside wall of the capsular bag along at least 90% of the equator of the capsular bag.

6. Method according to claim 1 , in which the at least one sharp edge of the object has a radius of less than 2 μm.

7. Method according to claim 1 , in which the lens-forming composition comprises polysiloxane.

8. Method according to claim 7 , in which the lens-forming composition comprising polysiloxane has a specific gravity of greater than about 1.0, a refractive index suitable for restoring the refractive power of the natural crystalline lens, and a viscosity suitable for injection of the composition through a standard cannula.

9. Method according to claim 7 , in which the lens-forming composition comprises polysiloxane of a siloxane monomer unit —R a R b SiO—, wherein R a and R b are the same or different alkyl or phenyl groups, at least one of which is substituted with at least one fluorine atom.

10. Method according to claim 7 , in which the lens-forming composition comprises polysiloxane that is a terpolymer or higher polymer of three or more different siloxane monomer units.

11. Method according to claim 7 , in which the lens-forming composition comprises polysiloxane that is a terpolymer of (a) dimethylsiloxane, (b) methylphenylsiloxane or diphenylsiloxane, and (c) trifluoropropylmethylsiloxane monomers.

12. Method according to claim 7 , in which the lens-forming composition comprises polysiloxane having crosslinkable groups, and further comprises a crosslinking agent and optionally an effective amount of a catalyst.

13. Method according to claim 1 , in which the lens-forming composition comprises a hydrogel.

14. Method according to claim 1 , in which the mammal is a human being.

15. Method according to claim 1 , for prevention of secondary cataracts.

16. Method according to claim 1 , for prevention of posterior capsule opacification.

17. Method according to claim 1 , for prevention of anterior capsule opacification.

18. Method according to claim 1 , for prevention of a condition characterized by irregular growth and/or irregular migration of epithelial cells in the capsular bag of the eye.

19. Method according to claim 1 , wherein the formed lens completely fills the capsular bag.